外周动脉疾病血管内介入治疗后患者的管理 - Suppr

Management of patients after endovascular interventions for peripheral artery disease.

作者信息

Sobieszczyk Piotr, Eisenhauer Andrew

机构信息

Interventional Cardiology & Vascular Medicine, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

出版信息

Circulation. 2013 Aug 13;128(7):749-57. doi: 10.1161/CIRCULATIONAHA.113.001560.

DOI:10.1161/CIRCULATIONAHA.113.001560

PMID:23940389

Abstract

摘要

相似文献

Management of patients after endovascular interventions for peripheral artery disease.外周动脉疾病血管内介入治疗后患者的管理

Circulation. 2013 Aug 13;128(7):749-57. doi: 10.1161/CIRCULATIONAHA.113.001560.

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).美国评估使用 Protégé Everflex Nitinol STent System II（耐久性 II）治疗股浅动脉和腘动脉近端病变的研究。

J Vasc Surg. 2013 Jul;58(1):73-83.e1. doi: 10.1016/j.jvs.2012.12.066. Epub 2013 May 2.

Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.西洛他唑减少西洛他唑治疗股腘动脉病变的血管内治疗后的血管造影再狭窄。

Circulation. 2013 Jun 11;127(23):2307-15. doi: 10.1161/CIRCULATIONAHA.112.000711. Epub 2013 May 7.

12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.6024例患者中当代血管内器械治疗股腘动脉闭塞性疾病的12个月主要通畅率：超越球囊血管成形术。

Catheter Cardiovasc Interv. 2014 Oct 1;84(4):555-64. doi: 10.1002/ccd.25510. Epub 2014 May 8.

Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting.联合开放式股动脉内膜切除术与血管腔内股腘动脉血管成形术及支架植入术治疗股浅动脉闭塞症

Ann Vasc Surg. 2011 May;25(4):559.e19-23. doi: 10.1016/j.avsg.2011.02.004.

Twelve-month experience with the GORE® TIGRIS® Vascular Stent in the superficial femoral and popliteal arteries.股浅动脉和腘动脉使用戈尔®TIGRIS®血管支架的一年经验。

J Cardiovasc Surg (Torino). 2015 Feb;56(1):89-95. Epub 2014 Nov 20.

A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention.抗血栓治疗综述以及外周动脉疾病（ePAD）患者中随机使用依度沙班试验的基本原理和设计：在股腘动脉血管腔内介入术后，将依度沙班或氯吡格雷添加至阿司匹林治疗。

J Endovasc Ther. 2015 Apr;22(2):261-8. doi: 10.1177/1526602815574687.

SUPERA interwoven nitinol Stent Outcomes in Above-Knee IntErventions (SAKE) study.SUPERA编织镍钛诺支架用于膝上干预的效果（SAKE）研究

J Vasc Interv Radiol. 2014 Jun;25(6):954-61. doi: 10.1016/j.jvir.2014.03.004. Epub 2014 Apr 24.

Effectiveness of sarpogrelate after endovascular treatment for femoropopliteal artery disease: ESPALIER study.沙格雷酯用于股腘动脉疾病血管内治疗后的疗效：ESPALIER研究

Cardiovasc Interv Ther. 2017 Oct;32(4):325-332. doi: 10.1007/s12928-016-0414-0. Epub 2016 Jul 25.

Drug delivering technology for endovascular management of infrainguinal peripheral artery disease.药物输送技术在治疗下肢外周动脉疾病的血管内治疗中的应用。

JACC Cardiovasc Interv. 2014 Aug;7(8):827-39. doi: 10.1016/j.jcin.2014.05.008.

引用本文的文献

Increased long-term bleeding complications in females undergoing endovascular revascularization for peripheral arterial disease.女性外周动脉疾病血管内再通治疗后长期出血并发症增加。

J Vasc Surg. 2022 Oct;76(4):1021-1029.e3. doi: 10.1016/j.jvs.2022.04.048. Epub 2022 Jun 11.

Endovascular Treatment for Critical Limb Ischemia in Type II Diabetes Mellitus Involving Femoropopliteal and Infrapopliteal Segments: Revascularization Strategy.腔内治疗在涉及股腘和腘下段的 II 型糖尿病伴发严重肢体缺血中的应用：血运重建策略。

Vasc Health Risk Manag. 2021 Mar 4;17:69-76. doi: 10.2147/VHRM.S298435. eCollection 2021.

Tackling Elevated Risk in PAD: Focus on Antithrombotic and Lipid Therapy for PAD.治疗 PAD 中的高风险：关注 PAD 的抗血栓和降脂治疗。

Curr Cardiol Rep. 2020 Jan 29;22(3):13. doi: 10.1007/s11886-020-1264-z.

Supervised exercise therapy and revascularization: Single-center experience of intermittent claudication management.监督下的运动疗法和血运重建：间歇性跛行管理的单中心经验。

Vasc Med. 2019 Jun;24(3):208-215. doi: 10.1177/1358863X18821175. Epub 2019 Feb 22.

ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine.美国心脏病学会适当使用标准工作组、美国心脏协会、心血管血管造影和介入学会、介入放射学会和血管医学学会 2018 年外周动脉介入适当使用标准：一份报告

J Am Coll Cardiol. 2019 Jan 22;73(2):214-237. doi: 10.1016/j.jacc.2018.10.002. Epub 2018 Dec 17.

Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease.ANMCO/ANCE/ARCA/GICR - IACPR/GISE/SICOA共识文件：冠状动脉疾病患者的长期抗血小板治疗

Eur Heart J Suppl. 2018 May;20(Suppl F):F1-F74. doi: 10.1093/eurheartj/suy019. Epub 2018 May 31.

Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis.噻吩并吡啶类药物的癌症发生率和死亡率：一项系统评价与荟萃分析。

Drug Saf. 2017 Mar;40(3):229-240. doi: 10.1007/s40264-016-0481-2.

Rationale and Design of Randomized Clinical Trial for the Assessment of Macitentan Efficiency as Coadjuvant Treatment to Open and Endovascular Revascularization in Critical Limb Ischemia.评估马昔腾坦作为严重肢体缺血开放和血管内血运重建辅助治疗有效性的随机临床试验的原理与设计

Clin Med Insights Cardiol. 2016 Nov 3;10:181-185. doi: 10.4137/CMC.S38448. eCollection 2016.

Management of Critical Limb Ischemia.严重肢体缺血的管理

Circ Cardiovasc Interv. 2016 Feb;9(2):e001946. doi: 10.1161/CIRCINTERVENTIONS.115.001946.

Endovascular intervention for peripheral artery disease.外周动脉疾病的血管内介入治疗

Circ Res. 2015 Apr 24;116(9):1599-613. doi: 10.1161/CIRCRESAHA.116.303503.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of patients after endovascular interventions for peripheral artery disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献